Actively Recruiting
Heparin-binding Protein and Lungedema in ICU Patients.
Led by Umeå University · Updated on 2026-03-10
25
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this single center observational cohort study is to investigate the relationship between physiological measures of lung oedema, and the biomarker Heparin-binding Protein (HBP). The main questions it aims to answer are: * Does the concentration of HBP in plasma correlate with measures of lung vascular permeability and extravascular water in the lungs? * Does the concentration of HBP in plasma correlate with the patient's total accumulated fluid balance? Researchers will collect blood samples and gather information on lung vascular permeability and extravascular lung water in Intensive care patients who are provided with a hemodynamic surveillance system called PiCCO. The study will include 25 patients.
CONDITIONS
Official Title
Heparin-binding Protein and Lungedema in ICU Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients >18 years
- Monitored with a PiCCO system
You will not qualify if you...
- Patients transferred from another ICU
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICU
Östersund, Sweden
Actively Recruiting
Research Team
L
Line Samuelsson, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here